Premium
Therapeutic options in Charles Bonnet syndrome
Author(s) -
Batra A.,
Bartels M.,
Wormstall H.
Publication year - 1997
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1997.tb09917.x
Subject(s) - charles bonnet syndrome , carbamazepine , visual acuity , psychiatry , medicine , psychology , visual hallucination , pediatrics , surgery , epilepsy
The term ‘Charles Bonnet syndrome’ refers to visual pseudohallucinations occurring especially in elderly people with reduced visual acuity. Despite numerous case reports, few successful methods of treatment have been described. Therapies with classical neuroleptics, antidepressants or benzodiazepines have generally been found to be unpromising. Only with carbamazepine treatment has improvement been observed in a few cases. In the three cases reported here, we successfully treated the condition with the atypical neuroleptic melperone.